Search

Author/Creator Bernaards, Coen

1. Cost-effectiveness of obinutuzumab plus bendamustine followed by obinutuzumab monotherapy for the treatment of follicular lymphoma patients who relapse after or are refractory to a rituximab-containing regimen in the US. (3rd October 2018)

Authors:
Guzauskas, Gregory F.; Masaquel, Anthony; Reyes, Carolina; Bernaards, Coen; Krivasi, Tania; Veenstra, David L.
Journal:
Journal of medical economics
Issue:
Volume 21:Number 10(2018)
Page Start:
960
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Mericitabine and ritonavir‐boosted danoprevir with or without ribavirin in treatment‐naive HCV genotype 1 patients: INFORM‐SVR study. (19th June 2014)

Authors:
Gane, Edward J.; Pockros, Paul J.; Zeuzem, Stefan; Marcellin, Patrick; Shikhman, Anna; Bernaards, Coen; Zhou, Julian; Yetzer, Ellen S.; Ballester, Rosa; Dwyer, Cindy; Tong, Xiao; Nájera, Isabel; Bertasso, Anne; Hammond, Janet; Kindrick, Amy; Morcos, Peter N.; Smith, Patrick; Stancic, Saray; Shulm...
Journal:
Liver international
Issue:
Volume 35(2015)Supplement 1
Page Start:
79
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Understanding the effect of the HCV polymerase inhibitor mericitabine on early viral kinetics in the phase 2 JUMP‐C and PROPEL studies. (September 2014)

Authors:
Chen, Ya‐Chi; Bernaards, Coen; Kulkarni, Rohit; Moreira, Sebastian; Zhu, Yonghong; Chan, Anna; Badman, Ethan; Ackrill, Andrew; Thommes, James; Smith, Patrick F.
Journal:
British journal of clinical pharmacology
Issue:
Volume 78:Number 3(2014:Sep.)
Page Start:
533
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗